Nature: New target for Alzheimer's disease, Nanjing University Li Liang/Zeng Ke's team reveals
Time of Update: 2021-04-19
On April 1, 2021, Liang Li/Zeng Ke's research group from the School of Life Sciences, Nanjing University published a research paper titled Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration in the journal Nature Communications.
Nature | Clinical Trial Results of Vaccine Targeting IDH1 Mutant Glioma
Time of Update: 2021-04-19
Recently, the Michael Platten research group from the German Cancer Research Center published an article titled A vaccine targeting mutant IDH1 in newly diagnosed glioma in the journal Nature.
Nature: Bacterial peptides on the surface of tumor cells are expected to become a new target for cancer immunotherapy
Time of Update: 2021-03-27
com" target="_blank">/---Cancer immunotherapy may be promoted in an unexpected direction: bacteria residing in tumor cells.
Two new breakthroughs in Nature's anti-cancer: new epigenetic target-NSD3
Time of Update: 2021-03-26
Recently, two papers published in the journal Nature showed that the enzyme NSD3 that controls the addition of this marker has been mutated in some human cancers and has become extremely active.
Nature In-depth Report: CAR-T therapy breakthroughs continue to be the most promising of these new targets
Time of Update: 2021-03-23
More clinical studies are evaluating whether mesothelin-targeted CAR-T cell therapy can enhance T cell responses by combining immune checkpoint blockade.
Nature Biomedical Engineering: New nanoparticles can be targeted to treat tumors
Time of Update: 2021-02-24
Cholka, Yang-xin Fu, Baran D. Sumer, Hongtao Yu, Jinming Gao. Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nature Biomedical Engineering, 2021; DOI: 10.1038/s41551-020-00675-9MedSci Original Source: MedSci Original
Nature's latest report reveals: 4 popular target organs, TOP10 adaptation certificate
Time of Update: 2021-02-23
based on an analysis of clinical data from more than 3,000 patients over 20 years, the authors believe that AAV gene therapy is a safe, well-to-use and effective treatment.
Arjuna Natural targets energy bar market with genus plant extracts
Time of Update: 2021-02-07
Arjuna 's production process extracts the right level of nitrate from the leaves of the genus plant: 9 grams per 100 grams, higher than beetroot powder and beet juice.
Nature sub-journal paper details! CAR-T cells targeting CXCR5 are expected to treat feliestic lymphoma and chronic lymphocytic leukemia
Time of Update: 2021-01-27
easy to control. a clinical trial in progress, Hoepken stressed, "No laboratory can do such research alone." thanks to the successful collaboration of many colleagues at max-delbruck Molecular Medical Center and Berlin's Schalette School
Nature sub-journal interpretation! Scientists are expected to develop a new drug discovery strategy for "drug-free" drug targets!
Time of Update: 2021-01-12